Nom du produit:1H-1,2,3-Triazole-4-carboxylic acid, 1-(4-chlorophenyl)-5-[(triphenylphosphoranylidene)amino]-, ethyl ester

IUPAC Name:ethyl 1-(4-chlorophenyl)-5-[(triphenyl-λ⁵-phosphanylidene)amino]-1H-1,2,3-triazole-4-carboxylate

CAS:272123-45-2
Formule moléculaire:C29H24ClN4O2P
Pureté:97%
Numéro de catalogue:CM515995
Poids moléculaire:526.96

Unité d'emballage Stock disponible Prix($) Quantité
CM515995-1g in stock ƋƋǠ
CM515995-5g in stock ſdžƋ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:272123-45-2
Formule moléculaire:C29H24ClN4O2P
Point de fusion:-
Code SMILES:O=C(C1=C(N=P(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)N(C5=CC=C(Cl)C=C5)N=N1)OCC
Densité:
Numéro de catalogue:CM515995
Poids moléculaire:526.96
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.